Chemotherapy agents: A primer for the interventional radiologist

Seminars in Interventional Radiology

Volumn 27, Issue 4, 2010, Pages 384-390

  Mihlon, Frank ^a   Ray, Charles E ^a,c   Messersmith, Wells ^b  

^a Division of Interventional Radiology   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NONE   (United States)

Author keywords

Cancer chemotherapy; Chemotherapy agents; Chemotherapy review; Principles of chemotherapy; Regional chemotherapy

Indexed keywords

EID: 78349260881     PISSN: 07399529     EISSN: 10988963     Source Type: Journal    
DOI: 10.1055/s-0030-1267852     Document Type: Article

References (25)

1. Howard A, Pelc S R. Nuclear incorporation of P32 as demonstrated by autoradiographs. Exp Cell Res 1951 2 (2) 178-187
2. Reed S. Cell cycle In: De Vita V, Hellman S, Rosenberg S Cancer: Principles & Practice of Oncology. Philadelphia Lippincott Williams & Wilkins 2005 83
3. Lees J. Control of the cell cycle In: Abeloff M, Armitage J, Niederhuber J, Kastan M, McKenna W Abeloff's Clinical Oncology. 4th ed. Philadelphia Churchill Livingstone/Elsevier 2008 50
4. Norton L. A Gompertzian model of human breast cancer growth. Cancer Res 1988 48 (24 Pt 1) 7067-7071
5. Goldie J H., Coldman A J. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979 63 (11-12) 1727-1733
6. Kinsella A R., Smith D. Tumor resistance to antimetabolites. Gen Pharmacol 1998 30 (5) 623-626 (Pubitemid 28167762)
7. Ray C, Koczwara B. Principles of chemotherapy In: Ray CE, Hicks ME, Patel NH Interventions in Oncology. Fairfax VA Society of Interventional Radiology 2003 9-15
8. Huitema A D., Smits K D., Matht R A., Schellens J H., Rodenhuis S, Beijnen J H. The clinical pharmacology of alkylating agents in high-dose chemotherapy. Anticancer Drugs 2000 11 (7) 515-533
9. Hirsch J. An anniversary for cancer chemotherapy. JAMA 2006 296 (12) 1518-1520
10. Kummar S, Noronha V, Chu E. Antimetabolites In: De Vita V, Hellman S, Rosenberg S Cancer: Principles & Practice of Oncology. Philadelphia Lippincott Williams & Wilkins 2005 358
11. Lennard L. Therapeutic drug monitoring of antimetabolic cytotoxic drugs. Br J Clin Pharmacol 1999 47 (2) 131-143
12. Rowinsky E, Tolcher A. Antimicrotubule agents In: De Vita V, Hellman S, Rosenberg S Cancer: Principles & Practice of Oncology. Philadelphia Lippincott Williams & Wilkins 2005 390-411
13. Verstappen C C., Koeppen S, Heimans J J. et al. Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening. Neurology 2005 64 (6) 1076-1077
14. Takimoto C. Topoisomerase interactive agents In: De Vita V, Hellman S, Rosenberg S Cancer: Principles & Practice of Oncology. Philadelphia Lippincott Williams & Wilkins 2005 375-389
15. Colvin O, Friedman H. Alkylating agents In: DeVita V, Hellman S, Rosenberg S Cancer: Principles & Practice of Oncology. Philadelphia Lippincott Williams & Wilkins 2005 332-344
16. Copur M, Rose M, Chu E. Miscellaneous chemotherapeutic agents In: De Vita V, Hellman S, Rosenberg S Cancer: Principles & Practice of Oncology. Philadelphia Lippincott Williams & Wilkins 2005 417
17. Gately D P., Howell S B. Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer 1993 67 (6) 1171-1176
18. Johnson S, O'Dwyer P. Cisplatin and its analogues In: De Vita V, Hellman S, Rosenberg S Cancer: Principles & Practice of Oncology. Philadelphia Lippincott Williams & Wilkins 2005 344-358
19. Ito Y, Sasaki Y, Horimoto M et al. Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma. Hepatology 1998 27 (4) 951-958
20. Llovet J M., Ricci S, Mazzaferro V et al, SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008 359 (4) 378-390
21. Sondak V, Redman B. Pharmacology of cancer biotherapeutics In: De Vita V, Hellman S, Rosenberg S Cancer: Principles & Practice of Oncology. Philadelphia Lippincott Williams & Wilkins 2005 423-430
22. Mier J, Atkins M. Interleukin-2 In: De Vita V, Hellman S, Rosenberg S Cancer: Principles & Practice of Oncology. Philadelphia Lippincott Williams & Wilkins 2005 431-438
23. Marks P, Richon V, Miller T, Kelly W. Histone deacetylase inhibitors: new targeted anticancer drugs In: De Vita V, Hellman S, Rosenberg S Cancer: Principles & Practice of Oncology. Philadelphia Lippincott Williams & Wilkins 2005 439-445
24. Cheng J, Adams G, Robinson M, Weiner L. Monoclonal antibodies In: De Vita V, Hellman S, Rosenberg S Cancer: Principles & Practice of Oncology. Philadelphia Lippincott Williams & Wilkins 2005 445-456
25. Goetz M, Erlichman C, Loprinzi C. Pharmacology of endocrine manipulation In: De Vita V, Hellman S, Rosenberg S Cancer: Principles & Practice of Oncology. Philadelphia Lippincott Williams & Wilkins 2005 457-469